which propagates through skin and organs and converges to a small diseased volume, thus leaving the surrounding tissue unharmed. Yet the non-invasive ability of ultrasound, which makes this technology clinically attractive (e.g., infection-free, pain-less, etc.), has also made it difficult to study and control as the therapeutic activity occurs in deep and inaccessible regions. The Hunt fellowship funded my research to develop "acoustic vision" to enable the spatial, temporal, spectral, and quantitative imaging of ultrasonically generated activity deep within our body. With this technology, I have worked on numerous projects to both study the behavior of ultrasonic phenomena and develop methods to improve therapeutic capabilities.
The central acoustic phenomenon in my research is acoustic cavitation-acoustically driven bubble activity-which can be used as microscopic sites of thermal or mechanical activity. By designing ultrasonic parameters to drive cavitation nuclei, either endogenous to our body or artificially engineered (e.g., microbubbles or solid hydrophobic particles), a wide range of effects may be produced. Stable cavitation-the expansion and contraction of a bubble-can alter vessel permeability or open pores in cell membranes. Inertial cavitation-the unstable expansion of the bubble followed by a violent collapse due to the inertia of the surrounding media-has been associated with vessel rupture and rapid heat generation.
In therapeutic applications, microbubbles, which are small enough to circulate throughout our extensive network of microvessels, are typically injected intravenously and subsequently sonicated. I created a controlled environment by flowing microbubbles through a vessel in a tissuemimicking material (TMM). Upon sonication, the microbubbles radiated harmonic or broadband acoustic emissions, indicating stable or inertial cavitation, respectively. These emissions were captured using a sensor array and, with the passive acoustic mapping (PAM) algorithm, enabled characterization of cavitation dynamics (e.g., type, magnitude, distribution, and duration). At low ultrasonic pressures, stable cavitation could be maintained throughout a long pulse while being predictably distributed according to the shape of the ultrasonic focal volume. At high pressures, inertial cavitation dominated, but persisted for only 6-7 ms as microbubbles were rapidly destroyed. Interestingly, cavitation became progressively spatially biased upstream as it evolved during the pulse, thus showing a shift in the treated region. Multiple pulses emitted at rates below a flowdependent critical rate produced predictable and consistent cavitation dynamics. Above the critical rate, energy generated was unpredictable and spatially biased. My analysis provided new insight into the relationship between pulse shape and sequence with cavitation dynamics and the in vivo biological environment, which both helped explain ultrasonic bioeffects observed empirically and provided a basis for optimizing pulse designs for future applications.
I then employed acoustic cavitation in mice to locally trigger the release of drugs from capsules (e.g., liposomes), open vessels of the tumor to allow drug transfer from blood to tissue, and enhance drug penetration deep into the tumor's tissue microenvironment. To this end, several challenges needed to be overcome: the tumor microvascular environments are animal-, organ-, and disease-specific and therefore unpredictable, ultrasonically driven cavitation activity remains poorly understood in vivo, and rapid tumor growth rates make comprehensive tumor coverage essential for successful therapy. In my work, PAM was employed to monitor ultrasound therapy and assess treatment success. Solid breast cancer tumors in mice were exposed to ultrasound following injection of microbubbles and a therapeutic agent, either self-replicating cancer-targeting viruses or cavitation-sensitive capsules containing drugs. Many characteristics of the cavitation dynamics observed in the tumor were similar to what was observed in the TMM. However, distinct from the TMM study, was the inhomogeneous and unpredictable spatial distribution of cavitation activity at the first pulse, which was likely due to the tumor's vascular inhomogeneity. In addition, ultrasonic pulses required emission rates to be below 1 Hz in order to produce therapeutically relevant levels of cavitation activity. I was also able to correlate the location of inertial cavitation activity to the location of drug release from the capsules. Thus, by mechanistically understanding cavitation dynamics in vivo and mapping the treatment distribution, I was able optimize the efficiency and efficacy of delivering a cancer-targeting virus to tumors. My treatment resulted in inhibition of tumor growth rates and an increase in mouse survival.
I am grateful to the Hunt family and the Acoustical Society of America for the opportunity to contribute what I hope to be impactful findings to the scientific and engineering community. My experience has been an enjoyable and stimulating experience, having engaged a challenging problem and collaborated with excellent scientists at the University of Oxford. I am deeply indebted for the support and guidance, both personal and professional, by Prof. Constantin-C. Coussios. I am also grateful for faculty members including Dr. Robert Carlisle, Prof. Robin Cleveland, Dr. Eleanor Stride, and Prof. Len Seymour; post-doctoral scientists including Dr. Jamie Collin, Dr. Carl Jensen, Dr. Eleonora Mylonopoulou, Dr. Christian Coviello, Dr. Miriam Bazan-Peregrino, and Dr. Stephane Labouret; graduate students, including Dr. David Holroyd, Dr. Daniel Chung, Susan Graham, Joshua Owen, Sunali Bhatnagar, Liza Leung, Evelyn Buchner Santos, Edward Jackson, Graciela Mohamedi, Bassel Rifai, and Michael Molinari; and the entire Biomedical Ultrasonics, Biotherapy, and Biopharmaceuticals Laboratory.
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